Godavari Biorefineries validates European anti-cancer patents in Spain, the UK, and the EU. Molecule targets cancer cells/stem cells, and shows promise in breast/prostate cancer. Phase 1a trials are ongoing.

• Patent covers novel molecules effective against cancer cells and stem cells, enhancing treatment precision.
• Preclinical studies highlight efficacy and safety in breast and prostate cancers, and advanced solid tumors.
• Phase 1a trials assess safety in patients with advanced tumors and healthy volunteers.